Projeto
Biointeration studies of membrane-bound catechol-O-methyltransferase polymorphic variants with commercial Parkinson’s inhibitors
| Referência: | SFRH/BD/147519/2019 |
|---|---|
| Organização financiadora: | Fundação para a Ciência e a Tecnologia |
| Instituições associadas: | Universidade Nova de Lisboa |
Registos relacionados
Biointeration studies of recombinant HPV-16 oncoproteins to discover therapeutic inhibitors
Bolsa Doutoramento FCT: Biointeration studies of recombinant HPV-16 oncoproteins to discover therapeutic inhibitors [2020.06792.BD]
INNOVATIVE WATER-SOLUBLE PHYTOMATERIAL INHIBITORs FOR ALZHEIMERs AND PARKINSONs DISEASES PREVENTION
GENETIC BASES OF COLOUR POLYMORPHISM IN PHILAENUS SPECIES
A functional marker of commercial AMF isolates for sustainable agriculture
Commercialization of a first in class multiple sclerosis drug [780807]
STRUCTURAL, THERMODYNAMIC, AND KINETIC ASPECTS OF POLYMORPHISM IN MOLECULAR ORGANIC SOLIDS
HOW PERVASIVE IS THE EFFECT OF LOCAL ADAPTATION IN THE GENOME OF POLYMORPHIC POPULATIONS
MECANISMO MOLECULAR DE AGREGAÇÃO DA ALFA-SINUCLEÍNA E SUAS VARIANTES NA DOENÇA DE PARKINSON: DESENVOLVI- MENTO DE NOVAS ESTRATÉGIAS TERAPÊUTICAS
Smart ZnO membrane applied to motion sensing
S-Glutathionylation in Parkinson´s Disease.
Impact of commercial pollinators in native species – introgression patterns and parasite prevalence in bumblebees
Modeling the impact of deep intronic DNA variants on human health
Modeling the impact of deep intronic DNA variants on human health
The transcriptional landscape of Parkinson´s disease
Care for Late Stage Parkinsonism
DEVELOPMENT OF INHIBITORS OF DENGUE VIRUS ASSEMBLY
COMPUTATIONAL MODELING OF PHOSPHODIESTERASE 3 INHIBITORS
Characterising Trypanosoma tissue tropism: new perspectives for variant surface glycoproteins
Pharmacological Modulators of Parkinsons Disease-Associated Proteins
Using Mainstream Devices to Monitor Parkinson´s Disease
DECIPHERING THE ROLE SIRT2 IN PARKINSON DISEASE
Modulating Ire1 to prevent Parkinson' Disease
Underlying role of glycation in the pathogenesis of Parkinsons disease
Cognitive Disorders in Late-Stage Parkinson´s Disease
Cardiovascular risk factors associated with Parkinson´s disease
Modulating Ire1 to prevent Parkinson' Disease
Lipid-tagged peptides as entry inhibitors for respiratory viruses
BROAD-SPECTRUM FUSION INHIBITORS AGAINST ENVELOPED VIRUSES
Modeling the response to radiation: DNA repair inhibitors and protectors
Modeling the response to radiation: DNA repair inhibitors and protectors
Genetic polymorphisms and risk of coronary heart disease in Madeira. Interaction with cardiovascular risk markers and their role in prognosis.
DEVELOPMENT OF CLONAL CANCER CELL ESCAPE VARIANTS AS THE BASIS FOR RELAPSE IN ACUTE MYELOID LEUKEMIA
PRODUCTION AND MECHANISTIC EVALUATION OF THE STABILITY OF POLYMORPHIC ACTIVE PHARMACEUTICAL INGREDIENTS APIS INCORPORATED INTO TABLETS AND EXTRUDATES TO PSYCHIATRIC PATIENTS
BREAST CANCER CHEMOTHERAPEUTIC AGENTS: HOW BASE EXCISION REPAIR DNA POLYMORPHISMS COULD INFLUENCE DRUG RESPONSE
New drugs to target Neurodegenerattion and Neuroinflammation in Parkinson ´s Disease
Publicações relacionadas
Carregando publicações...